Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13420Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Taliyan, Rajeev | - |
| dc.date.accessioned | 2023-12-14T06:47:06Z | - |
| dc.date.available | 2023-12-14T06:47:06Z | - |
| dc.date.issued | 2017-10 | - |
| dc.identifier.uri | https://linkinghub.elsevier.com/retrieve/pii/S0022510X17326953 | - |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13420 | - |
| dc.description.abstract | Insulin resistance has been reported as a strong risk factor for Alzheimer’s disease (AD). However the molecular mechanisms of association between these still remain elusive. Recently, elevated level of histone deacetylases (HDACs) and reduced histone acetylation has been reported in AD patients.Thus, targeting HDACs could provide a novel therapeutic strategy for treating these co-morbid condition. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | Insulin | en_US |
| dc.subject | Histone deacetylases (HDACs) | en_US |
| dc.title | Histone deacetylase inhibitor, Valproic acid, ameliorates insulin resistance induced cognitive deficit in mice | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Department of Pharmacy | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.